PAPER Nicolay JP, Gatz S, Liebig G, Gulbins E, Lang F
SEARCH RESULTS
330883 RESULTS
PAPER Simonsen AH, Hansson SF, Ruetschi U, McGuire J, Podust VN, Davies HA, Mehta P, Waldemar G, Zetterberg H, Andreasen N, Wallin A, Blennow K
Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods.
Dement Geriatr Cogn Disord. 2007;23(4):246-50. Epub 2007 Feb 19 PubMed: 17310122PAPER Matsumoto Y, Yanase D, Noguchi-Shinohara M, Ono K, Yoshita M, Yamada M
Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.
Dement Geriatr Cogn Disord. 2007;23(4):241-5. PubMed: 17310121PAPER Kadir A, Darreh-Shori T, Almkvist O, Wall A, Långström B, Nordberg A
Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.
Psychopharmacology (Berl). 2007 May;191(4):1005-14. PubMed: 17310387PAPER Ames D, Ritchie C
Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?
Int Psychogeriatr. 2007 Feb;19(1):1-8. PubMed: 17310512PAPER Bodine C, Scherer MJ
Technology for improving cognitive function. A workshop sponsored by the US Interagency Committee on Disability Research (ICDR): reports from working groups.
Disabil Rehabil. 2006 Dec 30;28(24):1567-71. PubMed: 17178621PAPER Jeret JS
Prevalence and severity of microbleeds in a memory clinic setting.
Neurology. 2007 Jan 30;68(5):391; author reply 391. PubMed: 17261692PAPER Rotilio J, Stella AM
Molecular basis of neurodegenerative diseases.
Ital J Biochem. 2006 Sep-Dec;55(3-4):189-93. PubMed: 17274524PAPER Borroni B, Di Luca M, Padovani A
The effect of APOE genotype on clinical phenotype in Alzheimer disease.
Neurology. 2007 Feb 20;68(8):624; author reply 624. PubMed: 17310043PAPER Chuo LJ, Sheu WH, Pai MC, Kuo YM
Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease.
Dement Geriatr Cogn Disord. 2007;23(4):251-7. PubMed: 17310123Steve Barger on Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase.
COMMENT Kuhn et al. have produced a convincing body of work indicating that the type 2 receptor for IL-1 (IL-1R2) is processed by most of the same proteases that cleave the amyloid precursor protein. At first glance, the relevance of these events for Alzheimer di
Hassan Movahhed
Elan PharmaceuticalsSouth San Francisco, United States
Joe Ciccotosto
The University of MelbourneParkville, Australia
Daniel Dries
Juniata College Huntingdon, United States
PAPER Re F, Sironi M, Muzio M, Matteucci C, Introna M, Orlando S, Penton-Rol G, Dower SK, Sims JE, Colotta F, Mantovani A
Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function.
J Exp Med. 1996 Apr 1;183(4):1841-50. PubMed: 8666940Current Filters
- Date Range : All x